Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Crit Care Med. 2019 Sep;47(9):1235–1242. doi: 10.1097/CCM.0000000000003879

TABLE 1.

Common Vasoactive Medications Used in Extracorporeal Membrane Oxygenation Patients

Medication Titration Variables Considerations
Vasoconstrictors
 Norepinephrine MAPs > 65 Modest inotropic effect. May worsen microvascular dysfunction.
 Vasopressin MAPs > 65 Effective agent for vasoplegia. May worsen gut ischemia.
Vasodilators
 Sodium nitroprusside MAPs < 80 Risks of use include cyanide toxicity and methemoglobinemia.
Prolonged use may lead to tachyphylaxis.
 Nicardipine MAPs < 80 Uncertain effects on cardiac inotropy.
Inotropes
 Dobutamine Pulse pressure > 15 May induce mild to moderate vasodilation.
 Epinephrine Pulse pressure > 15 Vasoconstrictive effects complicate its use as a targeted inotropic agent.
 Milrinone Pulse pressure > 15 May induce moderate systemic vasodilation; decreases pulmonary vascular resistance.

MAP = mean arterial pressure.